Niki BioSolutions, Inc. Available-for-sale Equity Securities, Gross Unrealized Gain
Niki BioSolutions, Inc. (NIKI) reported Available-for-sale Equity Securities, Gross Unrealized Gain of $1.12 million for the 12-month period ending 2018-12-31, per its 20-F filed 2019-04-15.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleEquitySecuritiesGrossUnrealizedGain · last filed 2019-04-15
| Period end | Available-for-sale Equity Securities, Gross Unrealized Gain 10 month | Available-for-sale Equity Securities, Gross Unrealized Gain 12 month |
|---|---|---|
| 2018-12-31 | $1.12M 20-F · filed 2019-04-15 | |
| 2017-12-31 | $367.78K 20-F · filed 2019-04-15 |